Edition:
United States

Biotechnology & Medical Research

Page 1

OncoTherapy Science announces change of president

Sunday, 26 Feb 2017 09:57pm EST

OncoTherapy Science Inc <4564.T> : Says co appoints Kazuo Yamamoto as new president, replacing Masaharu Mori who resigns .Change will be effective on Feb. 27.

Amir Efrati reports passive stake of 9 pct in Alcobra Ltd

Friday, 24 Feb 2017 05:40pm EST

Alcobra Ltd : Amir Efrati reports passive stake of 9 percent in alcobra ltd as on Feb. 22, 2017 .Amir Efrati had previously reported passive stake of 7.5 percent in Alcobra Ltd as of Jan. 23, 2017.

Frazier Healthcare VI L.P. reports 16.28 percent stake in Sierra Oncology as on Feb 14 - SEC filing

Friday, 24 Feb 2017 03:37pm EST

Sierra Oncology Inc :Frazier Healthcare VI L.P. reports 16.28 percent stake in Sierra Oncology as on February 14, 2017 - sec filing.

Oryzon Genomics FY net loss widens to 5.4 million euros vs year ago

Friday, 24 Feb 2017 11:48am EST

Oryzon Genomics SA : FY net loss 5.4 million euros ($5.71 million) versus loss 992,000 euros year ago . FY net sales 735,000 euros versus 4.3 million euros year ago .FY research and development expenses at 5.2 million euros, of which 4.3 million euros correspond to development and 0.9 million euros to research.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary